Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a strategic agreement to accelerate the development of new targeted therapies that respond to unmet clinical...
Read More
The Innovative SME Seal, valid for three years, recognizes the high level of innovation in the projects, products and services of Chemotargets. Barcelona, June 1st, 2021. Chemotargets has been awarded…
